Skip to content
  • About
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Trial Updates
    Treatment
    Surgery
    Prevention
    View all Topics
  • Conferences
    ACTRIMS Forum 2021
    CONy 2020
    MDS 2020
    AAIC 2020
    FENS 2020
    EAN 2020
    View all Conferences
  • Features
    • About
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Debating controversies in ALS 2:54
Debating controversies in ALS
Ettore Beghi • 27 Oct 2020
COVID-19: managing neurodegenerative diseases in southern Italy 6:13
COVID-19: managing neurodegenerative diseases in southern Italy
Giancarlo Logroscino • 22 Oct 2020
Potential environmental triggers of sporadic ALS 2:32
Potential environmental triggers of sporadic ALS
Peter Spencer • 19 Oct 2020
The reconstructed cohort design: tracking rare neurodegenerative diseases 4:40
The reconstructed cohort design: tracking rare neurodegenerative diseases
Giancarlo Logroscino • 22 Oct 2020
Potential toxins causing sporadic ALS: nitrosamines and hydrazines 2:40
Potential toxins causing sporadic ALS: nitrosamines and hydrazines
Peter Spencer • 19 Oct 2020
Identifying new therapeutic targets for neurodegenerative diseases 1:34
Identifying new therapeutic targets for neurodegenerative diseases
Bart De Strooper • 19 Oct 2020
Cycad toxins driving the ALS-Parkinsonism-Dementia complex 2:40
Cycad toxins driving the ALS-Parkinsonism-Dementia complex
Peter Spencer • 19 Oct 2020
ALS and FTD future research 1:51
ALS and FTD future research
Yuliya Shpilyukova • 17 May 2020
Genetics and ALS 0:48
Genetics and ALS
Rosario Vasta • 25 May 2020
ALS and FTD: current treatment landscape 1:40
ALS and FTD: current treatment landscape
Yuliya Shpilyukova • 17 May 2020
A new prognostic model for ALS 3:31
A new prognostic model for ALS
Rosario Vasta • 25 May 2020
C9orf72 hexanucleotide repeat expansion in ALS and FTD 2:31
C9orf72 hexanucleotide repeat expansion in ALS and FTD
Yuliya Shpilyukova • 17 May 2020
Plateaus in ALS progression 2:18
Plateaus in ALS progression
Rosario Vasta • 25 May 2020
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy